Reaching maturity - 25 years of the TDR.
In its first 25 years of existence, TDR has become a key player in the development of new tools for the control of tropical diseases and the training of researchers from disease-endemic countries. In order to maintain its leading position, cope with new health challenges and profit from new avenues opened by science and technology breakthroughs, a new strategic vision is now being implemented. It aims at a closer interaction with health systems and disease control programmes, capacity strengthening based on selected research initiatives and full exploitation of scientific and technological advances in the biomedical, social and information sciences, as discussed here by Carlos Morel.
Morel
C M
CM
TDR - World Health Organization, 20 Avenue Appia, CH-1211 27, Geneva, Switzerland. morelc@who.int
D000349:Africa; D014355:Chagas Disease / Q000517:prevention & control; D003715:Dengue / Q000517:prevention & control*; D004501:Education, Medical; D004605:Elephantiasis, Filarial / Q000517:prevention & control; D006801:Humans; D007896:Leishmaniasis / Q000517:prevention & control; D007918:Leprosy / Q000517:prevention & control*; D008288:Malaria / Q000517:prevention & control; D009855:Onchocerciasis / Q000517:prevention & control; D010272:Parasitic Diseases / Q000517:prevention & control*; D012552:Schistosomiasis / Q000517:prevention & control; D014330:Tropical Medicine / Q000706:statistics & numerical data*; D014353:Trypanosomiasis, African / Q000517:prevention & control; D014376:Tuberculosis / Q000517:prevention & control*; D014944:World Health Organization